Inflammation and oxidative stress markers in diabetes and hypertension

References

• who.int [homepage on the Internet]Raised blood pressureGenevaWorld Health Organization2008 Available from: http://www.who.int/cardiovascular_diseases/en/Accessed May 21, 2017
   Google Scholar
• LongANDagogo-JackSThe comorbidities of diabetes and hypertension: mechanisms and approach to target organ protectionJ Clin Hypertens (Greenwich)201113424425121466619
   PubMed Web of Science ®Google Scholar
• AlderAIStrattonIMNeilHAAssociation of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetesBMJ2000321725841241910938049
   PubMed Web of Science ®Google Scholar
• YannoutsosAAhouahMTubianaCDTopouchianJTouboulCSafarMEBlacherJHemodynamic parameters in hypertensive diabetic patientsJ Hypertens20163461123113126999754
   PubMed Web of Science ®Google Scholar
• NdisangJFVannacciARastogiSOxidative stress and inflammation in obesity, diabetes, hypertension, and related cardiometabolic complicationsOxid Med Cell Longev2014201450694824723993
   PubMed Web of Science ®Google Scholar
• DuarteDASilvaKCRosalesMALopes de FariaJBLopes de FariaJMThe concomitance of hypertension and diabetes exacerbating retinopathy: the role of inflammation and oxidative stressCurr Clin Pharmacol20138426627723173956
   PubMedGoogle Scholar
• SowerJREpsteinMDiabetes mellitus and associated hypertension, vascular disease, and nephropathy. An updateHypertension1995266 Pt 18698797490142
   PubMed Web of Science ®Google Scholar
• CheungBMLiCDiabetes and hypertension: is there a common metabolic pathway?Curr Atheroscler Rep201214216016622281657
   PubMed Web of Science ®Google Scholar
• SaviniICataniMVEvangelistaDGasperiVAviglianoLObesity-associated oxidative stress: strategies finalized to improve redox stateInt J Mol Sci2013145104971053823698776
   PubMed Web of Science ®Google Scholar
• JelinekHFAl-AubaidyHAMaschirowLMeidingerSJamilDAButkowskiEGlutathione:Glutathione sulfide redox imbalance in early impaired fasting glucoseCardiology and Angiology An International Journal201424223229
   Google Scholar
• MaschirowLKhalafKAl-AubaidyHAJelinekHFInflammation, coagulation, endothelial dysfunction and oxidative stress in prediabetes–Biomarkers as a possible tool for early disease detection for rural screeningClin Biochem201548958158525753569
   PubMed Web of Science ®Google Scholar
• ButkowskiEGBrixLMAl-AubaidyHAKiatHJelinekHJDiabetes, oxidative stress and cardiovascular riskJ Med Clin Sci2016511723
   Google Scholar
• NwoseEURichardsRSMcDonaldSJelinekHFKerrRGTinleyRAssessment of diabetic macrovascular complications: a prediabetes modelBr J Biomed Sci2010672596620669760
   PubMed Web of Science ®Google Scholar
• LibbyPSimonDIInflammation and thrombosis: the clot thickensCirculation2001103131718172011282900
   PubMed Web of Science ®Google Scholar
• BetteridgeDJWhat is oxidative stress ?Metabolism2000492 Suppl 138
   PubMed Web of Science ®Google Scholar
• RodrigoRPratHPassalacquaWArayaJGuichardCBächlerJPRelationship between oxidative stress and essential hypertensionHypertens Res200730121159116718344620
   PubMed Web of Science ®Google Scholar
• GrossmanEDoes increased oxidative stress cause hypertension?Diabetes Care200831Suppl 2S18518918227483
   PubMed Web of Science ®Google Scholar
• Al-AubaidyHAJelinekHF8-Hydroxy-2-deoxy-guanosine identifies oxidative DNA damage in a rural prediabetes cohortRedox Rep201015415516020663291
   PubMed Web of Science ®Google Scholar
• HinokioYSuzukiSHiraiMSuzukiCSuzukiMToyotaTUrinary excretion of 8-oxo-7,8-dihydro-2′-deoxyguanosine as a predictor of the development of diabetic nephropathyDiabetologia200245687788212107732
   PubMed Web of Science ®Google Scholar
• JelinekHFJamilDAAl-AubaidyHAImpaired fasting glucose & 8-IsoProstaglandin F2α in diabetes disease progressionBr J Med Med Res201443352295237
   Google Scholar
• DaviGCiabattoniGConsoliAIn vivo formation of 8-iso-prostaglandin F2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementationCirculation19999922242299892587
   PubMed Web of Science ®Google Scholar
• NatarajanRLantingLGonzalesNNadlerJFormation of an F2-isoprostane in vascular smooth muscle cells by elevated glucose and growth factorsAm J Physiol19962711 Pt 2H159H1658760171
   PubMed Web of Science ®Google Scholar
• SueishiKIchikawaKKatoKNakagawaKChenYXAtherosclerosis: coagulation and fibrinolysisSemin Thromb Hemost19982432552609701457
   PubMed Web of Science ®Google Scholar
• EsmonCTThe interactions between inflammation and coagulationBr J Haematol2005131441743016281932
   PubMed Web of Science ®Google Scholar
• FrinkRJInflammatory atherosclerosis: characteristics of the injurious agentSacramento (CA)Heart Research Foundation2002
   Google Scholar
• MojtabaEMahdiKKasbparastMAmirSSerum interleukin-1 beta plays an important role in insulin secretion in type II diabeticInternational Journal of Biosciences2011139399
   Google Scholar
• ChamarthiBWilliamsGHRicchiutiVInflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humansAm J Hypertens201124101143114821716327
   PubMed Web of Science ®Google Scholar
• HumbertMMontiGBrenotFIncreased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertensionAm J Respir Crit Care Med19951515162816317735624
   PubMed Web of Science ®Google Scholar
• DinarelloCADonathMYMandrup-PoulsenTRole of IL-1beta in type 2 dabetesCurr Opin Endocrinol Diabetes Obes201017431432120588114
   PubMed Web of Science ®Google Scholar
• van ExelEGusseklooJde CraenAJFrölichMBootsma-van der WielAWestendorpRGLeiden 85 Plus StudyLow production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-Plus StudyDiabetes20025141088109211916930
   PubMed Web of Science ®Google Scholar
• LimaVVZemseSMChiaoCWBomfimGFTostesRCClinton WebbRGiachiniFRInterleukin-10 limits increased blood pressure and vascular RhoA/Rho-kinase signaling in angiotensin II-infused miceLife Sci201614513714326682936
   PubMed Web of Science ®Google Scholar
• ContiEPitoccoDCapoluongoEZuppiCGhirlandaGCreaFAndreottiFIGF-1 and macrovascular complications of diabetesDiabetes Care20032651653165412716855
   PubMed Web of Science ®Google Scholar
• TeppalaSShankarAAssociation between serum IGF-1 and diabetes among U.S. adultsDiabetes Care2010332257225920639451
   PubMed Web of Science ®Google Scholar
• SchutteAEVolpeMTocciGContiERevisiting the relationship between blood pressure and insulin-like growth factor-1Hypertension20146351070107724566078
   PubMed Web of Science ®Google Scholar
• PaneeJMonocyte chemoattractant protein 1 (MCP-1) in obesity and diabetesCytokine201260111222766373
   PubMed Web of Science ®Google Scholar
• PiemontiLCaloriGLattuadaGAssociation between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individualsDiabetes Care200932112105211019641159
   PubMed Web of Science ®Google Scholar
• American Diabetes AssociationDiagnosis and classification of diabetes mellitusDiabetes Care2010331S626920042775
   PubMed Web of Science ®Google Scholar
• Guide to management of hypertension 2008Heart Foundation2010 Available from: https://www.heartfoundation.org.au/images/uploads/publications/HypertensionGuidelines2008to2010Update.pdfAccessed May 21, 2017
   Google Scholar
• KjeldsenSFeldmanRDLishengLUpdated national and international hypertension guidelines: a review of current recommendationsDrugs201474172033205125315030
   PubMed Web of Science ®Google Scholar
• Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultationPart 1: Diagnosis and classification of diabetes mellitusGenevaWorld Health Organization1999 Available from: http://apps.who.int/iris/handle/10665/66040Accessed May 21, 2017
   Google Scholar
• McCormackTKrauseTO’FlynnNManagement of hypertension in adults in primary care: NICE guidelineBr J Gen Pract20126259616316422429432
   PubMed Web of Science ®Google Scholar
• YanQSunDLiXAssociation of blood glucose level and hypertension in elderly Chinese subjects: a community based studyBMC Endocr Disord20161614027412111
   PubMed Web of Science ®Google Scholar
• SavoiaCSchiffrinELVascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventionsClin Sci (Lond)2007112737538417324119
   PubMed Web of Science ®Google Scholar
• Al-ShukailiAAL-GhafriSAl-MarhoobiSAl-AbriSAl-LawatiJAl-MaskariMAnalysis of inflammatory mediators in type 2 diabetes patientsInt J Endocrinol2013201397681023762057
   PubMed Web of Science ®Google Scholar
• TiwariBKPandeyKBAbidiABRizviSIMarkers of oxidative stress during diabetes mellitusJ Biomark2013201337879026317014
   PubMedGoogle Scholar
• BroedbaekKWeimannAStovgaardESPoulsenHEUrinary 8-oxo-7,8-dihydro-2′-deoxyguanosine as a biomarker in type 2 diabetesFree Radic Biol Med20115181473147921820047
   PubMed Web of Science ®Google Scholar
• Al-DaghriNMBindahmanLSAl-AttasOSIncreased circulating ANG II and TNF-alpha represents important risk factors in obese saudi adults with hypertension irrespective of diabetic status and BMIPloS One2012712e5125523251471
   PubMed Web of Science ®Google Scholar
• DinhQNDrummondGRSobeyCGChrissobolisSRoles of inflammation, oxidative stress, and vascular dysfunction in hypertensionBiomed Res Int2014201440696025136585
   PubMed Web of Science ®Google Scholar
• KimHYChaHJKimHSCCL5 upregulates IL-10 expression and partially mediates the antihypertensive effects of IL-10 in the vascular smooth muscle cells of spontaneously hypertensive ratsHypertens Res2015381066667425971630
   PubMed Web of Science ®Google Scholar
• JohnsonAGNSAIDs and increased blood pressure. What is the clinical significance?Drug Saf19971752772899391772
   PubMed Web of Science ®Google Scholar
• ZhangLCurhanGCFormanJPPlasma insulin-like growth factor-1 level and risk of incident hypertension in non-diabetic womenJ Hypertens201129222923521045735
   PubMed Web of Science ®Google Scholar
• SukhanovSSnarskiPHigashiYShaiSDelafontainePInsulin-like growth factor I (IGF-1) reduces chemokines and recruitment of monocytes into atherosclerotic plaque: potential mechanism mediating IGF-1 induced atheroprotectionFASEB J2015291
   Google Scholar
• StumpfCRaazDKlinghammerLSchneiderMSchmiederREGarlichsCDAchebachSPlatelet CD40 contributes to enhanced monocyte chemoattractant protein 1 levels in patients with resistant hypertensionEur J Clin Invest201646656457127090943
   PubMed Web of Science ®Google Scholar
• ArendtBKVelaszquez-DonesATschumperRCHowellKGAnsellSMWitzigTTJelinekDFInterleukin 6 induces monocyte chemoattractant protein-1 expression in myeloma cellsLeukemia200216102142214712357369
   PubMed Web of Science ®Google Scholar
• Al-ShantiNStewartCEInhibitory effects of IL-6 on IGF-1 activity in skeletal myoblasts could be mediated by the activation of SOCS-3J Cell Biochem2012113392393322033984
   PubMed Web of Science ®Google Scholar